英科醫療(300677.SZ)擬在上海投設全資子公司
格隆匯5月12日丨英科醫療(300677.SZ)公佈,為滿足公司業務發展需要,結合公司實際情況,公司擬在上海出資設立全資子公司上海英麥國際貿易有限公司(暫定名,以最終註冊為準,“上海英麥”),公司直接或間接持有上海英麥100%的股權。
在上海設立全資子公司目的是為設立投資貿易平台,符合公司長期發展戰略和投資方向,有利於公司的長期和持續發展,有利於進一步增強公司的整體實力,提升公司業績,鞏固公司在行業內的地位。資金來源為公司自有資金或自籌資金,符合公司戰略發展方向,不會對公司的生產經營產生不利影響,不存在損害公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.